These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11310669)

  • 21. Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulants.
    King FD; Hadley MS; Joiner KT; Martin RT; Sanger GJ; Smith DM; Smith GE; Smith P; Turner DH; Watts EA
    J Med Chem; 1993 Mar; 36(6):683-9. PubMed ID: 8459397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
    Park JS; Im W; Choi S; Park SJ; Jung JM; Baek KS; Son HP; Sharma S; Kim IS; Jung YH
    Eur J Med Chem; 2016 Feb; 109():75-88. PubMed ID: 26761776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the pharmacology of gastrointestinal prokinetics.
    Tonini M
    Pharmacol Res; 1996; 33(4-5):217-26. PubMed ID: 8938012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luminal 5-HT
    Gwynne RM; Bornstein JC
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13708. PubMed ID: 31524331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo.
    Eglen RM; Bonhaus DW; Johnson LG; Leung E; Clark RD
    Br J Pharmacol; 1995 Aug; 115(8):1387-92. PubMed ID: 8564196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT
    Tsubouchi T; Kunimatsu T; Tsujimoto S; Kiyoshi A; Katsura Y; Oku S; Chihara K; Mine Y; Yamada T; Shimizu I; Bando K
    Eur J Pharmacol; 2018 May; 826():96-105. PubMed ID: 29501863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, gastrointestinal prokinetic activity and structure-activity relationships of novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives.
    Sakaguchi J; Nishino H; Ogawa N; Iwanaga Y; Yasuda S; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):202-11. PubMed ID: 1576675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon.
    Ji SW; Park HJ; Cho JS; Lim JH; Lee SI
    Yonsei Med J; 2003 Aug; 44(4):653-64. PubMed ID: 12950122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
    Yoshikawa T; Yoshida N; Oka M
    Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colonic 5-HT
    Galligan JJ
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14125. PubMed ID: 33749067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives.
    Harada H; Morie T; Hirokawa Y; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1364-78. PubMed ID: 7553982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
    Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
    Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent.
    Kato S; Morie T; Yoshida N
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):699-702. PubMed ID: 7600620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of the selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist (+)-(S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-y l]aniline.
    Suzuki T; Iwaoka K; Imanishi N; Nagakura Y; Miyata K; Nakahara H; Ohta M; Mase T
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):120-2. PubMed ID: 9987833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides.
    Kato S; Morie T; Harada H; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):652-60. PubMed ID: 1535291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.